Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

NCT00920972 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Disorders
Hematologic, Immune, or Bone Marrow Disorders
Hemoglobinopathies
Non-malignant Disorders

Interventions

DRUG: Treatment Plan 1: Stratum 1
DRUG: Treatment Plan 2: Strata 2, 3, or 4
DRUG: GVHD Regimen A: UCB Recipients
DRUG: GVHD Regimen B: BM Recipients

Sponsor

Washington University School of Medicine

Collaborators

[object Object]